Release date: 9 December 2020
Promoter – Financial Intermediary
REPUBLIC OF GHANALocation
Description
The project aims at supporting the Government of Ghana in its COVID-19 national response plan. This includes acquisition of medical equipment and supplies, medicines, logistics, as well as the strengthening of the medical health system.
Objectives
The project is supporting the "National Strategic Covid-19 Response Plan" of the Ghanaian Government to fight COVID-19. It includes acquisition of medical equipment and supplies, increasing existing healthcare infrastructure for COVID-19, medicines, as well as healthcare system strengthening. The COVID-19 pandemic is anticipated to trigger severe shortages in the epidemiological area, healthcare services delivery and supply of critical consumables in an already under-financed and over-stretched health sector. The project is key, first to save human lives and second, to prepare the system for a likely possible further escalation and spread of the COVID-19 pandemic in Ghana.
Comments
The project is expected to contribute towards the achievement of Sustainable Development Goal (SDG) 3 (Good Health and Well-Being), to which both the EU and the EIB are fully committed.
Sector(s)
- Health - Human health and social work activities
Under ELM Guarantee
This operation is covered by the ELM Guarantee.
Under Global Europe NDICI guarantee
Under EFSD+ Guarantee
Proposed EIB finance (Approximate amount)
EUR 82 million
Total cost (Approximate amount)
EUR 90 million
Environmental aspects
The Promoter will implement the project in accordance with the Bank's Environmental and Social Principles and Standards.
Procurement
The Promoter will implement the project in accordance with the Bank's Guide to Procurement.
Status
Signed - 10/12/2021
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).